4YBI | Crystal structure of BACE with amino thiazine inhibitor LY2811376 | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Timm, D.E. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.84 | ||||||||||||
ligand | 4B2, GOL | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor., May PC, Dean RA, Lowe SL, Martenyi F, Sheehan SM, Boggs LN, Monk SA, Mathes BM, Mergott DJ, Watson BM, Stout SL, Timm DE, Smith Labell E, Gonzales CR, Nakano M, Jhee SS, Yen M, Ereshefsky L, Lindstrom TD, Calligaro DO, Cocke PJ, Greg Hall D, Friedrich S, Citron M, Audia JE, J Neurosci. 2011 Nov 16;31(46):16507-16. doi: 10.1523/JNEUROSCI.3647-11.2011. PMID:22090477 |
Data retrieval |
View 4YBI in 3D |
Visual 3D analysis of 4YBI |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4YBI |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |